IBM joins in cancer research, diagnosis

November 9, 2005

The IBM Corp. announced Tuesday it is joining forces with several research centers to help accelerate cancer research, diagnosis and treatment.

IBM, based in Armonk, N.Y., said it will collaborate with the Memorial Sloan-Kettering Cancer Center, the Molecular Profiling Institute and the CHU Sainte-Justine Research Center under separate agreements.

IBM and Sloan-Kettering will build a state-of-the-art integrated information management system to improve the ability of clinicians and researchers to study long-term cancer-related illnesses, identify disease trends and determine success rates.

"This is an excellent multi-sector model that can drive integration of molecular medicine into areas where it's truly needed, including cancer detection, treatment, and ultimately prevention," said Dr. Anna Barker, deputy director of the National Cancer Institute. "The convergence of advanced technologies and post-genomics science will change cancer medicine in ways we cannot yet envision."

Copyright 2005 by United Press International

Explore further: Boston Children's Hospital to tap IBM Watson to tackle rare pediatric diseases

Related Stories

Hydrogel improves delivery of anti-cancer drug

November 1, 2013

The Institute of Bioengineering and Nanotechnology (IBN) and IBM Research (IBM) have developed a new non-toxic hydrogel that is capable of shrinking breast cancer tumors more rapidly than existing therapies. As described ...

Recommended for you

Amazon deforestation leaps 16 percent in 2015

November 28, 2015

Illegal logging and clearing of Brazil's Amazon rainforest increased 16 percent in the last year, the government said, in a setback to the aim of stopping destruction of the world's greatest forest by 2030.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.